0R15 7603.0 -1.7651% 0R1E 7406.0 -1.3848% 0M69 None None% 0R2V 168.75 -0.8811% 0QYR 1341.134 1.2177% 0QYP 392.5 -4.0342% 0LCV 132.52 -0.8084% 0RUK 2940.0 0.616% 0RYA 1742.0 -2.1348% 0RIH 157.95 -0.2211% 0RIH 155.51 -1.5448% 0R1O 171.25 9561.4951% 0R1O None None% 0QFP 8920.4336 76.9927% 0M2Z 296.7062 -0.5009% 0VSO 23.61 -33.6891% 0R1I None None% 0QZI 492.5 -0.1014% 0QZ0 220.0 0.0% 0NZF 859.0151 72.3546%

small-cap

One FTSE AIM Listed Speculative Stock to Punt on: Numis Corporation

Nov 02, 2021 | Team Kalkine
One FTSE AIM Listed Speculative Stock to Punt on: Numis Corporation

 

Numis Corporation PLC

Numis Corporation PLC (LON: NUM) is a FTSE AIM UK 50 index listed independent institutional stockbroker and corporate advisor.

Upcoming Event: On 8 December 2021, Numis expects to release final results for FY21.

Rationale for Valuation – SPECULATIVE BUY at GBX 339.00

  • Positive Outlook: As pipeline remained robust, wider market outlook appears positive.
  • Good Momentum: Numis delivered a strong performance in Q4 FY21 and maintained its positive momentum. Given the favourable market backdrop, the Group has increased its capital allocation and delivered growth in top-line and bottom-line items.
  • Guidance: FY21 revenue is expected to be around £215 million (FY20: £154.9 million), and thus, profits are expected to be higher than FY20.
  • Undervalued Multiples: On a forward 12-month basis – EV/Sales, EV/EBITDA, and Price/Earnings valuation multiples of Numis are undervalued against the Investment Banking & Investment Services sector.

Key Risks

  • Macroeconomic Risk: The likelihood of China Evergrande’s debt default risk poses a systematic risk to the financial markets.
  • Market Risk: The Company is also exposed to market risk with high volatility in equity market, and loss of clients with subdued investors’ sentiments.

Trading Update (for the year ending 30 September 2021, as on 30 September 2021)

  • Revenue Growth: During FY21, revenues from Investment Banking division grew considerably to £150 million in FY21 (FY20: £101.7 million).
  • Revenue Expectation: Revenue for H2 FY21 is expected to be higher than H2 FY20, reflecting a significant volume of COVID related capital markets transactions.
  • Bright Prospects: Numis’ pipeline also remained robust, and the wider market outlook is positive. It also expects to launch several IPOs in FY22, and continuing progress on its strategic priorities.

Share Price Chart (since 02 February 2021)

(Data Source: Refinitiv, Analysis done by Kalkine Group)

Valuation Methodology: Price/Earnings Approach (FY21) (Illustrative) 

Conclusion 

FY21 remained an excellent year for Numis, and it well-positioned to generate incremental shareholders’ value. The M&A and private markets transactions contributed significant revenue and market share gains. It also experienced resilient research payments, and good activity levels in UK equities. Therefore, the Company’s prospects look appealing to invest at the current level. The stock made a 52 week High and Low of GBX 419.86 and GBX 286.00, respectively. 

Based on robust revenue growth, strong profit generation, significant progress on strategic priorities, favourable market dynamics, supported by the valuation conducted above, we have given a “SPECULATIVE BUY” recommendation on Numis Corporation PLC at the current market price of around GBX 339.00 (as on 02 November 2021 at 08:28 AM GMT), with lower double-digit upside potential based 9.16x Price/Earnings (approx.) on FY21E Earnings Per Share (approx.). 

*Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached or if the price closes below the support level (indicative stop-loss price).

*The reference data in this report has been partly sourced from REFINITIV.

*All forecasted figures and Peers/ Industry information have been taken from Refinitiv.

*Dividend Yield may vary as per the stock price movement.


Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions